Sarepta Therapeutics Inc’s recently made public that its EVP, General Counsel Brown Ryan Edward unloaded Company’s shares for reported $6.3 million on Jun 25 ’24. In the deal valued at $161.61 per share,38,957 shares were sold. As a result of this transaction, Brown Ryan Edward now holds 17,129 shares worth roughly $2.47 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Arif Bilal sold 3,898 shares, generating $636,271 in total proceeds. Upon selling the shares at $163.23, the Chief Tech Ops Officer now owns 17,363 shares.
Before that, Arif Bilal sold 7,859 shares. Sarepta Therapeutics Inc shares valued at $1,281,621 were divested by the Chief Tech Ops Officer at a price of $163.08 per share. As a result of the transaction, Arif Bilal now holds 21,261 shares, worth roughly $3.06 million.
RBC Capital Mkts upgraded its Sarepta Therapeutics Inc [SRPT] rating to an Outperform from a a Sector perform in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in late June from “a Buy” to “a Neutral”. Piper Sandler began covering SRPT with “an Overweight” recommendation on May 31, 2024. RBC Capital Mkts revised its rating on May 28, 2024. It rated SRPT as “a Sector perform” which previously was an “an Outperform”.
Price Performance Review of SRPT
On Friday, Sarepta Therapeutics Inc [NASDAQ:SRPT] saw its stock fall -0.05% to $143.94. Over the last five days, the stock has lost -0.21%. Sarepta Therapeutics Inc shares have risen nearly 49.27% since the year began. Nevertheless, the stocks have risen 36.84% over the past one year. While a 52-week high of $173.25 was reached on 06/21/24, a 52-week low of $55.25 was recorded on 01/05/24. SMA at 50 days reached $139.05, while 200 days put it at $119.21. A total of 1.18 million shares were traded, compared to the trading of 1.32 million shares in the previous session.
Levels Of Support And Resistance For SRPT Stock
The 24-hour chart illustrates a support level at 141.33, which if violated will result in even more drops to 138.71. On the upside, there is a resistance level at 145.62. A further resistance level may holdings at 147.29. The Relative Strength Index (RSI) on the 14-day chart is 48.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.50%. Stochastics%K at 20.17% indicates the stock is a holding.
